These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 6086508)

  • 1. Enalpril (MK-421) induced attenuation of norepinephrine induced responses in isolated perfused rat mesentery.
    Gulati N; Huggel H; Gulati OP
    Indian J Exp Biol; 1984 Jan; 22(1):57-8. PubMed ID: 6086508
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of angiotensin-converting enzyme inhibitor Hoe-498 on noradrenaline-induced vasoconstriction in isolated perfused mesentery of rats.
    Xiang JZ; Schölkens BA
    Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):104-5. PubMed ID: 6087609
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML; Kurz KD; Schenck KW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
    Jover B; Dupont M; Casellas D; Mimran A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo.
    Chu ZM; Croft KD; Kingsbury DA; Falck JR; Reddy KM; Beilin LJ
    Clin Sci (Lond); 2000 Mar; 98(3):277-82. PubMed ID: 10677385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the vasoconstrictor responses to potassium depolarization and norepinephrine and their antagonism by differing classes of vasodilators in the perfused rat hindquarters.
    Sybertz EJ; Vander Vliet G; Baum T
    J Pharmacol Exp Ther; 1983 Dec; 227(3):621-6. PubMed ID: 6317841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of converting enzyme inhibition: studies in experimental animals.
    Dinicolantonio R; Mendelsohn FA; Takata Y; Hutchinson JS; Doyle AE
    Neth J Med; 1984; 27(4):153-60. PubMed ID: 6330589
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
    García VM; Monasterolo LA; Elías MM
    Acta Diabetol; 2003 Sep; 40(3):130-6. PubMed ID: 14605969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal dose of PGE1 in the rat mesentery against vasoconstrictive effect of norepinephrine].
    Kato T; Sugiura Y; Harada J; Saito M; Takahashi K; Goto Y; Yamamoto K; Aochi O
    Masui; 1984 Jul; 33(7):720-4. PubMed ID: 6542152
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal prostaglandin E in the hypotensive mechanism of MK-421 in conscious rats.
    Yasujima M; Abe K; Tanno M; Kasai Y; Sato K; Tajima J; Kudo K; Tsunoda K; Yoshinaga K
    J Hypertens; 1984 Dec; 2(6):623-9. PubMed ID: 6098610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
    Sweet CS; Gross DM; Arbegast PT; Gaul SL; Britt PM; Ludden CT; Weitz D; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):558-66. PubMed ID: 6259323
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta.
    Vercruysse L; Morel N; Van Camp J; Szust J; Smagghe G
    Peptides; 2008 Feb; 29(2):261-7. PubMed ID: 18221823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS; Cherry WF; Terrell JA; Ulm EH
    Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.